List view / Grid view

Timothy Coetzee

 

news

FDA approves Genzyme’s AUBAGIO®

AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing Multiple Sclerosis...

12 September 2012 | By Sanofi

AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing Multiple Sclerosis...